Skip to main content
Geratherm Medical AG logo

Geratherm Medical AG — Investor Relations & Filings

Ticker · GME ISIN · DE0005495626 LEI · 391200RRY20H0XD6QC53 F Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 483 across all filing types
Latest filing 2023-11-20 Transaction in Own Shar…
Country DE Germany
Listing F GME

About Geratherm Medical AG

https://geratherm.com/

Geratherm Medical AG is a medical technology company that develops and produces a range of medical devices and solutions for both professional and home use. For the professional market, the company provides systems for pulmonary function diagnostics, including spirometry, pulmonary function tests (PFT), and cardiopulmonary stress tests (CPET). It also offers specialized equipment such as the nomag®IC advanced, an MR diagnostics incubator system for newborns. For the consumer and home care market, Geratherm offers a portfolio of healthcare diagnostic products designed to monitor vital data. This includes clinical thermometers, blood pressure monitors, and products for women's health, such as pregnancy tests and tools for natural family planning.

Recent filings

Filing Released Lang Actions
Geratherm Medical AG: Veroffentlichung einer Kapitalmarktinformation
Transaction in Own Shares Classification · 100% confidence The document is a 'Kapitalmarktinformation' (Capital Market Information) from Geratherm Medical AG, dated November 20, 2023. The key subject is 'Aktienrückkauf: Bekanntmachung nach Artikel 5 Abs. 1 b) und Abs. 3 der Verordnung (EU) Nr.596/2014' (Share Buyback: Announcement according to Article 5...). It details the number of shares repurchased between November 13 and November 17, 2023, including daily volumes and weighted average prices. This specific activity—reporting on the company's own share transactions—directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a regulatory announcement, the specific nature of the content (buyback details) makes POS a more precise classification than the general 'RNS' or 'RPA'. The document length is short (3351 chars), but it contains the substantive data, not just a notice that data is available elsewhere.
2023-11-20 German
Geratherm Medical AG: Veroffentlichung einer Kapitalmarktinformation
Transaction in Own Shares Classification · 100% confidence The document is titled 'Geratherm Medical AG: Veröffentlichung einer Kapitalmarktinformation' and explicitly details the 'Aktienrückkauf: Bekanntmachung nach Artikel 5 Abs. 1 b) und Abs. 3 der Verordnung (EU) Nr.596/2014' (Share Buyback: Announcement according to Article 5...). It provides a table showing the number of shares repurchased daily between November 6 and November 10, 2023, along with weighted average prices. This content directly relates to the company acquiring its own shares. According to the definitions, 'Transaction in Own Shares (Code: POS)' covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. Although it is an announcement, the core subject matter is the transaction itself, making POS the most specific fit over a general RPA or RNS.
2023-11-13 German
Geratherm Medical AG: Veroffentlichung einer Kapitalmarktinformation
Transaction in Own Shares Classification · 100% confidence The document is titled "Geratherm Medical AG: Veröffentlichung einer Kapitalmarktinformation" and explicitly mentions "Aktienrückkauf: Bekanntmachung nach Artikel 5 Abs. 1 b) und Abs. 3 der Verordnung (EU) Nr.596/2014" and "Erwerb eigener Aktien – 37. Zwischenmeldung". This content details the daily acquisition of the company's own shares over a specific period (Oct 30 to Nov 03, 2023). This directly corresponds to the definition of a Transaction in Own Shares (share repurchase/issuance), which is classified as 'POS'. Although it is a regulatory announcement, the specific nature of the transaction (share buyback details) makes POS a more precise fit than the general 'RNS' or 'RPA'. The document length is short (3349 chars), but it contains the substantive data rather than just announcing an attached report.
2023-11-06 German
Geratherm Medical AG: Veroffentlichung einer Kapitalmarktinformation
Transaction in Own Shares Classification · 100% confidence The document is a short corporate announcement dated October 30, 2023, titled "Geratherm Medical AG: Veröffentlichung einer Kapitalmarktinformation" (Publication of a Capital Market Information). The key content revolves around the "Aktienrückkauf" (Share Buyback) and provides the 36th interim report on the acquisition of own shares, detailing daily transactions, volumes, and compliance with EU regulations (Regulation (EU) No 596/2014). This is a specific disclosure regarding the company's own shares being transacted. According to the definitions, 'Transaction in Own Shares' (Code: POS) covers reports of the company buying back or selling its own shares. Since this document explicitly details the results of the ongoing share repurchase program, POS is the most accurate classification. It is not a general regulatory filing (RNS) because it fits a specific category, and it is not an announcement of a report (RPA) because it contains the actual data/results.
2023-10-30 German
Geratherm Medical AG: Veroffentlichung einer Kapitalmarktinformation
Transaction in Own Shares Classification · 100% confidence The document is titled "Geratherm Medical AG: Veröffentlichung einer Kapitalmarktinformation" and explicitly states under the heading "Aktienrückkauf: Bekanntmachung nach Artikel 5 Abs. 1 b) und Abs. 3 der Verordnung (EU) Nr.596/2014" that it concerns the "Erwerb eigener Aktien – 35. Zwischenmeldung" (Acquisition of own shares - 35th interim report). This content details the number of shares repurchased, the dates, and the volume-weighted average price, which directly relates to the company buying back its own stock. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). Although it is a regulatory announcement, the specific subject matter (share repurchase details) makes POS a more precise classification than the general RNS.
2023-10-23 German
Geratherm Medical AG: Veroffentlichung einer Kapitalmarktinformation
Transaction in Own Shares Classification · 100% confidence The document is titled "Geratherm Medical AG: Veröffentlichung einer Kapitalmarktinformation" (Publication of a Capital Market Information) and explicitly mentions "Aktienrückkauf: Bekanntmachung nach Artikel 5 Abs. 1 b) und Abs. 3 der Verordnung (EU) Nr.596/2014" (Share Buyback: Announcement according to Article 5...). It details the number of shares repurchased over a specific period (October 2nd to October 6th, 2023). This content directly relates to the company acquiring its own shares, which corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a regulatory announcement (indicated by EQS News and EU regulation references), the specific subject matter is the share repurchase program, making POS the most precise classification over the general RNS.
2023-10-09 German

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.